| Literature DB >> 27651151 |
Honglin Yan1, Jingping Yuan2, Likun Gao1, Jie Rao1, Jichang Hu1.
Abstract
Maternally expressed gene 3 (MEG3) is suggested to function as a long non-coding RNA (lncRNA) and to play roles in various human cancers. However, the functional properties of MEG3 in ischemic stroke remain unknown. Here, we report that expression of MEG3 is upregulated following ischemia in adult mice. Moreover, cerebral ischemia recruits p53 into the MEG3 complex in ischemic tissues. MEG3 directly binds with the p53 DNA binding domain (DBD) consisting of amino acids 271-282 (p53-DBD271-282), which stimulates p53-mediated transactivation and mediates ischemic neuronal death. Administration of the membrane-permeable peptide inhibitor Tat-p53-DBD271-282 uncouples p53 from MEG3 in vivo and protects against cerebral ischemic insults in vitro and in vivo. Our data demonstrate that MEG3 functions as a cell death promoter in ischemia and physically and functionally interacts with p53 to mediate ischemic damage. Intervention in the MEG3-p53 interaction presents a new target for the therapeutic treatment of ischemic insults.Entities:
Keywords: Tat-p53-DBD(271–282); ischemia; maternally expressed gene 3; neuronal death; p53
Mesh:
Substances:
Year: 2016 PMID: 27651151 DOI: 10.1016/j.neuroscience.2016.09.017
Source DB: PubMed Journal: Neuroscience ISSN: 0306-4522 Impact factor: 3.590